Parker Waichman LLP

Boston Scientific Stent Approved Despite Problems

Boston Scientific Stent Approved by The FDA. Late last week, Boston Scientific Corporation announced that U.S. health regulators approved the next-generation version of its widely used Taxus drug-coated stent.  Boston Scientifc plans to begin selling the stent in early November. Meanwhile, in March, Boston Scientific received an approvable letter from the Food and Drug Administration (FDA) […]

Boston Scientific Stent

Boston Scientific Stent Approved by The FDA. Late last week, Boston Scientific Corporation announced that U.S. health regulators approved the next-generation version of its widely used Taxus drug-coated stent.  Boston Scientifc plans to begin selling the stent in early November.

Meanwhile, in March, Boston Scientific received an approvable letter from the Food and Drug Administration (FDA) for the stent, the Taxus Liberte

Receiving an approvable letter indicates that certain conditions must be met before full FDA approval is granted.  The company also received a corporate warning letter from the FDA in 2006.

Stents are tiny wire-mesh tubes used to prop open arteries after doctors clear them of blockages.  Newer stents are drug-coated to help prevent blood vessels from reclogging.  The Taxus Liberte Stent is already approved overseas, and is one of Boston Scientific’s best selling stents abroad; the Taxus Express is the top seller in the U.S. 

In considering approval of the Liberte, the FDA asked Boston Scientific to prove its anti-clogging performance in patients was “non-inferior” to the Taxus Express.  

Boston Scientific said structural design improvements over the original market-leading Taxus make the Liberte more flexible for easier insertion during angioplasty procedures.

Study used by Boston Scientific, when pursuing U.S. approval for its Taxus Liberte stent

Meanwhile, this summer, the Wall Street Journal reported that a study used by Boston Scientific, when pursuing U.S. approval for its Taxus Liberte stent, used a flawed equation favoring its stent.  According to the Journal, had Boston Scientific used one of several other calculation methods, the Liberte clinical trial would have failed. 

According to the Journal, Boston Scientific used the Wald interval, long criticized by statisticians for exaggerating clinical trial results. 

Worse, when publishing results of the 2006 Liberte study, Boston Scientific neglected to disclose it employed the Wald interval.

The Atlas study compared Taxus Liberte to the Taxus Express.  According to the findings touted by Boston Scientific, the Liberte’s anti-clogging performance in patients was “non-inferior” to the Taxus Express. 

According to the Journal, Boston Scientific said there was less than a five percent chance that its finding was wrong—a measure known as p-value.   In April 2007, in the Journal of the American College of Cardiology, the company’s researchers for the first time specified the p-value:  4.87 percent.

Scientists generally regard studies with p-values above five percent to be failures, and medical journals typically will not publish such results.

Journal’s own analysis of the Liberte study using equations other than the Wald interval

The Journal’s own analysis of the Liberte study using equations other than the Wald interval found that study’s p-value was about 5.1%—failing to rule out the possibility that patients getting the Liberte stent will have markedly more artery recloggings than those receiving the Express. 

The Journal also sited other problems with the Taxus Liberte study.  For example, because the Liberte stent uses a design similar to its predecessor, the Express, the FDA allowed the company to conduct an easier test than would be required for a newer product and allowed Boston Scientific to omit a control  group of patients newly implanted with the Express. 

Instead, Boston Scientific was allowed to compare the Liberte’s fresh results with data it had collected on Express patients years earlier.  Boston Scientific also didn’t have to “blind” participants in the study. 

Patients and doctors were aware that the stent being implanted was the model on trial—a Liberte. That can lead to a placebo effect, according to the Journal article.

Need Legal Help Regarding Boston Scientific Stent?

The personal injury attorneys at Parker Waichman LLP offer free, no-obligation case evaluations. For more information, fill out our online contact form or call 1-800-YOURLAWYER (1-800-968-7529).

[sc name=”post-footers”]

What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
I have had such charming experiences when calling. Both Catherine Nunez and Jillian have been such great helps, they answer every question I may have and are always willing to help. This is my first time dealing with a law firm so was scared at first but they have both made this process so easy thus far. Great in every aspect. Also, the nurse consultant Joanne Stevens has been on top of my medical injuries & treatment making sure all that needs to get done is. They’ve all been making this process as smooth as they can for me.
Carmen Rodriguez
5 years ago
5 Star Reviews 150
Excellent professionals who fulfill their commitment..
William Contreras
3 years ago
5 Star Reviews 150
I can't thank Yesenia and the team at Parker Waichman for helping me with my case. I was treated with the most professional help and respect. I can't thank them enough for handling everything without ease and always keeping me updated on my case. This was my first case dealing with lawyers and Yesenia guided me and was very knowledgable. Thank you again to her and everyone at Parker Waichman!
Perry Shum
4 years ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard
Suite 108
Bonita Springs, FL 34134
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038